Skip to main content
Top
Published in: Endocrine 1/2018

01-07-2018 | Endocrine Surgery

Comment on Microsurgical therapy of pituitary adenomas

Author: Michael Buchfelder

Published in: Endocrine | Issue 1/2018

Login to get access

Excerpt

In this article [1], Mortini et al. review their extensive experience with the surgical treatment of pituitary adenomas. Their results, in terms of tumor resection and normalization rates of hormonal oversecretion are outstanding, while the complication rate is minimal. They extend a similar, previous report [2] to larger patient numbers and longer follow-up periods. The data presented convincingly show, which excellent results can be achieved with a microsurgical technique by an experienced surgeon in a specialized center with a high case load. Moreover, even the rare entities of pituitary adenomas, such as thyrotropinomas, are represented in impressive numbers [1]. The data furthermore show that adaption of the endoscopic method is not necessarily required, that in contrast, impressive results can be obtained by using microsurgical excellency and that microsurgery is not at all outdated in the therapy of pituitary tumors. Virtually all endoscopic series lack such high patient numbers and long-term outcome data. The authors can be congratulated not only to the remarkable outcome but also to this concise and well written publication that might serve as a reference for to date and even in the near future. …
Metadata
Title
Comment on Microsurgical therapy of pituitary adenomas
Author
Michael Buchfelder
Publication date
01-07-2018
Publisher
Springer US
Published in
Endocrine / Issue 1/2018
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1558-8

Other articles of this Issue 1/2018

Endocrine 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.